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The National Center for Emerging and Zoonotic Infectious Diseases (NCEZID) was established in 2010, with a mission 
and scientific activities that trace back to the earliest days of the Centers for Disease Control and Prevention (CDC). This 
document is a strategic roadmap for the work necessary during the next 5 years to realize the Center’s vision—prevent 
infection, protect people, and save lives.
NCEZID is responsible for the prevention and control of a wide range of 
infectious diseases, including rare but deadly diseases like anthrax and 
Ebola hemorrhagic fever, and more common illnesses like foodborne 
diseases and healthcare-associated infections. The Center’s expert staff 
manages a broad portfolio of science-based programs that also promote 
water safety, the health of migrating populations, and the identification 
and control of diseases transmitted by animals and insects (e.g., rabies, 
Lyme disease).  NCEZID works closely with the National Center for 
Immunization and Respiratory Diseases, the National Center for HIV/
AIDS, Viral Hepatitis, STD, and TB Prevention, and other parts of CDC to 
fulfill the agency’s commitment to protect against the spread of all infectious diseases.
NCEZID is one of the agency’s principal sources of epidemiologic and laboratory expertise about bacterial, viral, and 
fungal pathogens as well as infectious diseases of unknown origin. State and local health departments, other federal 
agencies, and foreign ministries of health look to NCEZID to assist with wide-ranging problems—from illness and death 
in 28 states caused by Listeria-contaminated cantaloupes, to an outbreak of anthrax in hippos and humans in Kenya, to 
rising rates of tuberculosis among people immigrating to the United States, to new outbreaks of dengue in south Florida. 
And, it is primarily because NCEZID’s diverse workforce includes a correspondingly broad spectrum of infectious disease 
expertise (see insert, pg. 2) that mysterious illnesses are identified, outbreaks are contained, and lives are saved.
None of this work could happen without an ever-expanding extensive network of partnerships. NCEZID collaborates 
with many public and private partners, most notably federal, state, and local public health departments, public health 
organizations, academia, industry, and global multilateral organizations and ministries of health.
CDC scientists in 2011 study bats in Uganda 
to learn more about their relationship to 
Marburg virus which, like Ebola virus, can 
cause a rare but deadly hemorrhagic fever 
in humans and other primates. 
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VISION: Prevent infections, protect 
people, save lives
 
MISSION: To reduce illness and 
death associated with emerging and 
zoonotic infectious diseases and to 
protect against the unintentional 
or intentional spread of infectious 
diseases
About the Strategic Plan
As noted by the Institute of Medicine, the “global 
interconnectedness” that has evolved during 
the past several decades has caused infectious 
pathogens to “…emerge more frequently, 
spread greater distances, pass more eas-
ily between humans and animals, and 
evolve into new and more virulent 
strains.”  Fortunately, there have also 
been recent significant advances in 
controlling the spread of disease. To address opportu-
nities and challenges brought about by vast scien-
tific, environmental, demographic, technological, 
and economic changes, NCEZID developed this 
strategic plan to identify the Center’s priority work 
for the next 5 years (2012–2017). 
Defining “priority work” is challenging, in part 
because of the sheer breadth of NCEZID’s work, 
as evidenced by its two-pronged mission—to 
reduce illness and death and to protect against the 
unintentional and intentional spread of infectious 
diseases. Current and projected economic realities 
require that difficult choices be made to ensure that 
the most essential activities and services related to 
the Center’s mission be sustained, or where pos-
sible, advanced. 
This strategic plan was created through the com-
bined efforts of the NCEZID Office of the Director 
and the Center’s seven divisions as well as partner 
engagement, both inside and outside CDC. The 
strategies and objectives presented here build upon 
the principles described in the Office of Infectious 
Diseases’ A CDC Framework for Preventing Infectious 
Diseases: Sustaining the Essentials and Innovating 
for the Future, which serves as a roadmap for all of 
CDC’s infectious disease work. The NCEZID strategic 
plan also aligns with CDC priorities to 
•  strengthen surveillance and epidemiology
1Institute of Medicine. Infectious Disease Movement in a 
Borderless World. Workshop Summary. March 12, 2010. 
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The success of NCEZID’s strategic plan 
will require continued leadership and 
excellence in a wide-range of diverse 
but interrelated areas such as:  
• Healthcare-associated infections
• Foodborne and waterborne diseases
• Vector-borne diseases
•  High-consequence/low-incidence 
  infectious diseases (e.g., anthrax)
•  Diseases of special and vulnerable 
  populations (e.g., Alaska Natives,
  refugees) 
•  Infectious disease public health,
  epidemiologic, and laboratory science
•  Detection of and response to disease
  outbreaks caused by specific bacterial,
  viral, and fungal organisms 
•  Domestic and global health safety and 
security, including preparedness against 
emerging infections and biothreats
•  Discovery of new pathogens and
  investigation of undefined illnesses
•  The interaction of pathogen, host, and 
the environment, including the complex 
interplay between human health, animal 
health, and the environment (i.e., One 
Health). 
•  State-of-the-art laboratory services and 
support for CDC’s infectious disease 
laboratories
•  Trend analysis, health economics, and  
  predictive science
•  Health communication, education, and
  behavioral science
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•  enhance the agency’s ability to 
support state and local public 
health
•  provide leadership in global 
health
•  promote effective public health 
policy
•  address the causes of death, 
illness, and disability
This document is not intended 
to be a comprehensive catalog 
of the plans for all NCEZID activities. Rather, it provides an outline of essential work that must be done to fulfill the Center’s 
mission, as well as emphasizing special, urgent initiatives and activities that could have a significant impact on the health of 
the nation going forward. The strategic plan provides clear, consistent, and carefully considered guidance focusing on key 
Center activities that will most efficiently and cost-effectively prevent infections, protect people, and save lives.
The strategic plan is divided into four overall strategies. Each strategy includes a set of selected strategic objectives for 
the next 5 years, which are supported by specific actions listed in bulleted form beneath. The first strategy, strengthen 
fundamentals, ensures a solid foundation of laboratory, surveillance, and epidemiologic investigation necessary for public 
health action to continue. The second strategy, implement interventions, defines the strategic direction for addressing 
the first part of the Center’s mission, “to reduce illness and death” associated with infectious diseases. The third strategy, 
enhance preparedness, focuses on the direction needed for the second part of the mission, “protect against the inten-
tional and unintentional spread of infectious diseases.”  The fourth and final strategy, support the NCEZID workforce, is 
essential to make the first three strategies happen. Ultimately, the success of the Center is dependent on the exceptional 
public health professionals who are dedicated to achieving the objectives outlined in the strategic plan. Finally, as 
NCEZID successfully implements this plan to inform and shape its work during the next 5 years, it will continue to 
maintain an unwavering commitment to these core values that have been guiding the center since its inception: 
•  Build programs on a foundation of quality science to reduce illness and death associated with emerging and zoonotic 
infectious diseases and protect against the unintentional or intentional spread of infectious diseases. 
•  Translate and disseminate specific pathogen-related expertise in support of all infectious disease-related federal, 
state, local, and global health activities.
•  Address the distinct needs of vulnerable populations by promoting health equity.
•  Engage in meaningful and transparent relationships with a wide range of public and private sector partners at the 
federal, state, local, and global levels.
•  Promote fiscal and program efficiencies for all public health-related activities within CDC and all other agencies of the 
U.S. government. 
•  Ensure that communications about the Center’s work are accurate, timely, and consistent. 
•  Champion the professional growth and development of the Center’s workforce and create a high-quality, professional, 
and rewarding work environment.
At any given time, about 1 in every 20 
patients has an infection related to their 
hospital care.
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Objective 1.1 Improve infectious disease surveillance, outbreak response, and epidemiology
•  Apply advances in scientific methodologies for surveillance, outbreak investigations, program evaluations, 
and applied research in order to improve early disease detection and response.
•  Provide leadership for programs and platforms (e.g., National Healthcare Safety Network, Emerging Infections 
Program) that can be used by CDC as well as public health and clinical partners for conducting high-priority 
work to prevent and control infectious diseases. 
•  Lead efforts to ensure that priority cross-cutting disease areas are addressed (e.g., vulnerable populations and 
health disparities).
•  Move toward seamless integration of epidemiologic and laboratory data.
•  Engage global partners in improving capacity to detect, respond to, and control infections.
•  Use evolving health information technology (IT) tools (e.g., electronic health records and portable digital 
information-capturing and -transmittal devices) to improve timely reporting and use of public health data at 
federal, state, and local levels.
Objective 1.2 Improve NCEZID core laboratory capacity and accelerate development and application of novel  
diagnostic methods
•  Apply new laboratory methods and information technology to advance infectious disease detection 
and response (e.g., whole genome sequencing, bioinformatics).
•  Create innovative, practical, and cost-effective laboratory tests (e.g., culture-independent and 
point-of-service laboratory tests) to provide more rapid diagnoses, especially in outside-of-health 
  care settings.
•  Improve the ability to rapidly translate 
diagnostic laboratory information into 
effective public health interventions.
•  Embrace a culture of continuous quality
   improvement to NCEZID laboratories to
   secure their identity as national and int
   national centers of high-quality reference  
   diagnostics.
STRATEGY 1: STRENGTHEN PUBLIC HEALTH FUNDAMENTALS
Advance and increase effectiveness of infectious disease laboratory science, surveillance, 
epidemiology, information technology, communications, and strategic partnerships to 
support high-quality public health programs
CDC scientists track antimicrobial-resistant pathogens 
around the globe. Antimicrobial resistance is one of the 
world’s most pressing health problems. 
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NCEZID STRATEGIC OBJECTIVES
Objective 1.3:  Strengthen state and local public health 
systems
•  Serve as effective steward for the Epidemiology and 
Laboratory Capacity for Infectious Diseases Cooperative 
Agreement to support epidemiologic investigations, 
laboratory infrastructure and expertise, and surveillance for 
state and local health departments.
•  Improve capacity of state and local health departments to 
develop metrics for assessing their impact and to enhance 
their ability to communicate objectives and accomplishments. 
•  Strengthen collaborations with CDC public health 
partners to bolster state and local public health program 
fundamentals and program delivery.
  
Objective 1.4: Leverage partnerships, policy, and effective 
communication messaging to protect the health of the public.
•  Bring together multidisciplinary and private sector experts 
to identify broad-based solutions to public health problems
  at the local and state levels (e.g., public-private collaborations on healthcare-associated infections).
•  Conduct high-level policy analysis and forecasting necessary to develop and guide targeted public health actions. 
•  Employ principles of clear communication and new communication channels (e.g., social media) to ensure that 
NCEZID science is effectively translated to promote broad public awareness and action. 
Each year, roughly 1 in 6 people in the United States gets sick (and 3,000 
die) from eating contaminated food. 
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STRATEGY 2: IMPLEMENT HIGH-IMPACT INTERVENTIONS 
Develop and apply the science to support and implement new and proven approaches to 
prevent and control infectious diseases in NCEZID programmatic priority areas 
Objective 2.1 Use targeted strategies to reduce the burden of foodborne and waterborne diseases
•  Enhance capacity to detect and respond to foodborne and diarrheal disease outbreaks to reduce the incidence 
of common, but preventable, infections.
•  Expand scientific information on the incidence, trends, burden, source attribution, and characteristics of 
foodborne pathogens and infections. 
•  Use what is learned from outbreaks, inspections, and monitoring systems to develop new and improve existing 
strategies for preventing foodborne disease.
•  Strengthen efforts to prevent water-, sanitation-, and hygiene (WASH)-related diseases domestically and globally.
Objective 2.2 Promote improved healthcare quality and patient safety
•  Work aggressively toward reaching the goal of eliminating healthcare-associated infections.
•  Promote the prevention of blood-, tissue-, and organ-associated infections and other adverse events to 
prevent the unintentional spread of infectious disease.
•  Strengthen monitoring and evaluation of adverse events following immunization in order to enhance vaccine 
safety.
•  Monitor and promote the prevention of common adverse events from the use of medications to prevent, for 
example, accidental overdoses.
Objective 2.3 Use established and innovative methods and tools to better prevent and control zoonotic and 
vector-borne diseases domestically and globally
•  Develop and validate prevention measures to prevent Lyme disease and other tick-borne infections. 
•  Improve integrated surveillance, diagnosis, and case management of vector-borne diseases to improve 
rapid response and treatment. 
•  Develop new methods and recommendations for surveillance, prevention, and control to help stop the 
spread of dengue.
•  Improve rapid diagnostic capacity for zoonotic diseases in humans and animals (e.g., developing and  
validating point-of-service diagnostic tests).
•  Advance efforts domestically and globally to prevent rabies through improved advocacy, surveillance, 
diagnostics, and biologics.
•  Develop innovative methods to reduce morbidity and mortality associated with vector-borne diseases 
globally (e.g., assessing novel rat-proof food storage containers to prevent the spread of plague  in 
Uganda).
•  Advance One Health approaches to prevent the emergence and spread of zoonotic diseases.
CDC scientists investigate an 
outbreak of Rocky Mountain spotted 
fever caused by an unusual type of 
tick, the brown dog tick.
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Objective 2.4 Increase public health, community, and individual 
action to prevent the spread of infectious disease in globally 
mobile populations (e.g., travelers) and in populations with 
increased risk for acquiring or transmitting infections (e.g., 
refugees, immigrants)
•  Enhance CDC’s ability to detect and respond to communicable 
diseases in U.S.-bound travelers, immigrants, and imported animals 
to prevent the introduction and spread of infectious disease.
•  Strengthen disease screening and prevention for globally mobile 
populations (e.g., tuberculosis prevention).
•  Promote engagement with partners to reduce cross-border disease 
spread.
•  Provide recommendations to safeguard the health of U.S. residents 
traveling internationally or living abroad.
•  Identify and implement infectious disease prevention strategies to 
help protect vulnerable populations.
Objective 2.5 Enhance strategies for reducing antimicrobial resistance
 
Effectively lead and coordinate activities designed to combat the complex and ever-changing problem of antimicrobial 
resistance (e.g., HHS interagency action plan to combat antimicrobial resistance).
•  Improve domestic and international surveillance for antimicrobial resistance.
•  Develop and promote the necessary tools to ensure appropriate antimicrobial use.
•  Improve rapid diagnostic capacity for antimicrobial resistance to help ensure that patients receive effective 
treatment.
Producing posters for display in airports is one way that CDC helps  
international travelers stay healthy. 
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STRATEGY 3: ENHANCE PREPAREDNESS 
In concert with partners, improve domestic and global public health preparedness, 
safety, and biosecurity, especially as related to the spread of high-consequence 
infectious diseases as well as to emerging pathogens 
Objective 3.1 Strengthen capacity for surveillance, epidemiologic investigations, and bioterrorism prevention 
and response 
•  Enhance capacity of federal, state, local, and other partners to detect, respond to, and prevent high-consequence 
infections, including those associated with bioterrorism (e.g., Bacillus anthracis), to protect the health of all 
U.S. citizens. 
•  Improve planning and operational preparedness through lessons learned from prior emergency responses.
•  Support infectious disease 
emergency response activities 
in collaboration with CDC and 
other federal partners.
•  Ensure that the needs of 
vulnerable populations are 
included in preparedness.
•  Develop and enhance medical 
countermeasures and non-
medical mitigation strategies 
to better protect the public’s 
health from the threat of  
bioterrorism.
 
Objective 3.2 Improve public health laboratory capacity for bioterrorism preparedness and response
•  Strengthen domestic and international laboratory systems to enhance biosecurity (e.g., improve capacity 
of the Laboratory Response Network for timely detection and characterization of biothreat agents).
•  Develop and validate new tools and tests to aid laboratory detection and identification of new, unknown, 
emerging, or bioterror disease threats.
•  Enhance CDC’s internal laboratory capacity to support preparedness, detection, and response activities.
Objective 3.3 Strengthen global capacity to detect and respond to international outbreaks of public health significance 
•  Improve global efforts to detect, prevent, and control emerging, high-consequence, and bioterrorism 
pathogens (e.g., working with international partners to strengthen epidemiology and laboratory capacity).
•  Advance the 2005 International Health Regulations (IHR) and other global health policies in collaboration 
with other U.S. and international partners.
•  Help develop capacity overseas to improve early detection of known and novel pathogens (e.g., prevention 
of Ebola viral hemorrhagic fever outbreaks in Africa).
•  Promote effective surveillance and intervention designed to prevent the importation of infectious diseases 
into the United States. 
•  Engage with partners to help control the spread of emerging infections. 
CDC staff member in the Biosafety Level 
4 laboratory decontamination shower. 
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Objective 4.1 Create and sustain a work environment that contributes to high levels of job satisfaction and a 
healthy work/life balance that supports the professional and personal priorities of all NCEZID staff
•  Promote a culture that encourages two-way communication between supervisory and nonsupervisory 
employees to identify what is working, new approaches, and systems improvements.
•  Actively support and recognize deserving personnel, especially for innovation, critical thinking, and 
individual and collective contributions.
•  Encourage work-life balance by establishing 
reasonable workload and performance 
expectations. 
•  Promote participation in employee feedback 
tools (e.g., the Employee Viewpoint Survey) 
   and ensure timely and appropriate responses 
   to concerns.
•  Champion the value of NCEZID’s multi-sectoral 
workforce and their important contributions to 
the Center’s work environment.
Objective 4.2 Attract, maintain, and develop 
a highly skilled, motivated and diverse work-
force to fulfill the mission of NCEZID
•  Develop an NCEZID recruiting approach 
that emphasizes appropriate competencies, 
such as scientific excellence, organizational 
management, and cultural sensitivity.
•  Ensure opportunities for recruiting and 
mentoring students and fellows (e.g., the 
Epidemic Intelligence Service).
•  Support the agency’s commitment to increasing 
diversity in the workforce (e.g., hiring initiatives 
for Hispanics and people with disabilities).
•  Maximize the use of CDC fellowship programs. 
Division of Scientific Resources staff stock laboratory 
supplies (such as glassware) and provide services for CDC’s 
high-containment laboratories, where scientists study lethal 
infectious pathogens. 
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STRATEGY 4: SUPPORT THE NCEZID WORKFORCE 
Continuously improve the NCEZID work environment and employees’ ability to perform 
and grow in a way that contributes to high job satisfaction
•  Actively plan for staff succession by identifying and 
recruiting people with appropriate skills and committing 
to develop competencies necessary for addressing future 
public health demands.  
Objective 4.3 Ensure that meaningful opportunities for 
training, professional development, and career enhancement 
are available to the entire NCEZID workforce
•  Encourage participation in training to promote scientific        
  excellence, strong leadership, and effective supervisory and 
administrative skills.
•  Ensure that supervisory and nonsupervisory staff work 
  collaboratively to use the Individual Development Plans   
  to maximize opportunities for career training and  
  development.
•  Support developmental detail opportunities as appropriate 
  for staff to gain skills and experience by working in other units within NCEZID and CDC.
•  Encourage employee participation in programs for education and mentoring.
Objective 4.4 Improve internal communication, performance appraisals, and other management tools to foster morale 
and promote a sense of teamwork which will contribute to NCEZID workforce efficiencies 
•  Develop and sustain effective communication mechanisms to consistently inform Center staff of priorities, 
progress, and the value of the work they do and its importance to NCEZID and CDC public health objectives.
•  Ensure that all Center leadership and staff are effectively engaged in the CDC performance appraisal system. 
•  Uniformly apply standards of fairness, consistency, and accountability in performance appraisals.
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CDC staff help coordinate the agency’s rapid response to bioterrorism and 
other infectious disease emergencies, such as the H1N1 flu outbreak.
